Southern African States Join To Encourage Local Pharmaceutical Industry

A new Southern African Generics Medicines Association (SAGMA) has been established to drive growth in the pharmaceutical sectors in the region. SAGMA plans to develop initiatives to encourage further investment and trade for local pharmaceutical firms operating in the region. Membership will be open to selected firms from 14 countries in Southern Africa. BMI believes the harmonisation of regulatory policies still remains one of the greatest barriers for generic drugmakers in the region and therefore will be observing SAGMA as it attempts to fulfil its core

To read the full article, please choose one of the following options: